Somnoware develops software for managing respiratory care. The company's core product is software to manage respiratory-care services. CerraCap Ventures announced a strategic investment in Somnoware on May 12, 2022. Financial details of the strategic investment were not disclosed. The companies said the investment will help accelerate Somnoware's expansion in sleep, respiratory care, and additional healthcare markets. The article does not report any operating metrics, prior financing amounts, or other financial details. Somnoware offers an AI-driven chronic respiratory healthcare platform currently used by sleep physicians and pulmonologists. The platform is available in two versions: Somnoware for Physicians and Somnoware for Testing Facilities, each tailored to different workflows. Physicians get instant access to diagnostic test data, e-signature capability, one-click DME ordering, CPAP compliance data, and end-to-end patient care management. Testing and pulmonary labs can automate scheduling across multiple centers, inventory management, automated reporting, therapy ordering, and AASM accreditation. The customer base includes health systems, accountable care organizations, independent test labs, and service companies. The company closed $3.5M in funding and intends to use the proceeds to accelerate market expansion and develop key AI technologies. Somnoware provides a cloud-based sleep wellness and sleep disorder management platform that connects, organizes and analyzes clinical information. The platform enables over 1,500 sleep physicians across 42 states to manage sleep apnea. Customers include Carolinas HealthCare, Delaware Sleep Disorders Center, Emerald Sleep Services, REM Sleep Center and Sunset Sleep Labs. Led by CEO Subath Kamalasan, Somnoware serves health systems, independent sleep centers and sleep services companies. The company secured $9M in Series A funding and intends to use the proceeds to expand operations.

Total raised

$13M

Funding rounds

3

Latest round

Equity

Latest activity

Apr 2018